DELCATH SYSTEMS, INC.

Develops targeted chemotherapy delivery systems for treating primary and metastatic liver cancers.

DCTH | NDAQ

Overview

Corporate Details

ISIN(s):: US24661P8077
LEI:
Country:: United States of America
Address:: 566 QUEENSBURY AVENUE, 12804 QUEENSBURY
Website:: https://delcath.com/
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

Delcath Systems, Inc. is a commercial-stage, interventional oncology company focused on treating primary and metastatic liver cancers. The company develops and commercializes specialty pharmaceutical and medical device products based on its proprietary percutaneous hepatic perfusion (PHP) technology. This minimally-invasive procedure is designed to deliver high-dose chemotherapy directly to the liver while controlling systemic side effects. Its flagship products are the HEPZATO KIT™, recently FDA-approved in the U.S. for treating metastatic uveal melanoma, and the CHEMOSAT® Hepatic Delivery System, a medical device available in Europe. Delcath aims to provide targeted, minimally-invasive treatment options for patients with liver-dominant cancers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all DELCATH SYSTEMS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DELCATH SYSTEMS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for DELCATH SYSTEMS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Menicon Co.,Ltd. A global manufacturer of contact lenses and eye care products, from R&D to sales in over 80 countries.	Japan	7780
Mercator Medical Global manufacturer and European distributor of single-use medical gloves and supplies.	Poland	MRC
METABIOMED.CO.,LTD Develops and manufactures dental, surgical, and bio-absorbable medical devices for global markets.	South Korea	059210
Microbot Medical Inc. Developing a single-use, disposable micro-robotic system for precise endovascular procedures.	United States of America	MBOT
Micro-NX Co., Ltd. Manufactures precision micro motor systems for dental, laboratory, and nail care applications.	South Korea	448780
Miris Holding AB Develops human milk analyzers and software for individualized nutrition in neonatal care.	Sweden	MIR
MITECH CO.,LTD. Develops and manufactures non-vascular metallic stents for the global healthcare industry.	South Korea	179290
Modular Medical, Inc. Developing a simple, affordable insulin pump for the diabetes market.	United States of America	MODD
Momina Krepost AD Manufactures medical consumables and plastic products for industrial and household applications.	Bulgaria	MKR
Monogram Technologies Inc. AI-driven orthopedic robotics for personalized joint replacement with 3D-printed implants.	United States of America	MGRM